Clinical trial
A Prospective, Multicenter, Randomized Controlled, Non-inferiority Clinical Study Evaluating the Efficacy and Safety of Intraparenchymal Portal Vein Covered Stents for the Treatment of Portal Hypertension and Its Complications
NCT06320912 is registered in ClinicalTrials.gov with Shanghai Shenqi Medical Technology Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized Controlled, Non-inferiority Clinical Study Evaluating the Efficacy and Safety of Intraparenchymal Portal Vein Covered Stents for the Treatment of Portal Hypertension and Its Complications
- Lead sponsor
- Shanghai Shenqi Medical Technology Co., Ltd
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- April 5, 2024
- Completion date
- November 1, 2026
- Enrollment
- 258 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
portal hypertension